Diffusion Pharmaceuticals... (DFFN)
NASDAQ: DFFN
· Real-Time Price · USD
4.40
0.41 (10.28%)
At close: Aug 16, 2023, 10:00 PM
Diffusion Pharmaceuticals Revenue Breakdown
| Period Ending | Sep 30, 2013 | Jun 30, 2013 |
|---|---|---|
| ProElite Revenue | 72 | 72 |
| ProElite Revenue Growth | 0.00% | n/a |
| Total Revenue | 72 | 72 |
| Total Revenue Growth | 0.00% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 3.27M | 2.38M | 1.58M | 2.21M | 2.51M | 2.41M | 2.22M | 2.96M | 2.34M | 2.13M | 2.14M | 2.13M | 1.94M | 1.93M | 1.84M | 1.74M | 1.48M | 2.11M | 1.46M | 1.39M | 1.27M | 1.29M | 1.07M | 1.2M | 1.42M | 1.59M | 1.66M | 1.5M | 1.28M | 1.56M | 1.8M | 1.55M | 1.02M | 3.85M | 2.35M | 3.86M | 2.61M | 1.46M | 2.85M | 1.96M |
| Selling, General, and Administrative Revenue Growth | +37.03% | +50.92% | -28.58% | -11.98% | +4.23% | +8.56% | -24.95% | +26.19% | +10.31% | -0.56% | +0.38% | +10.03% | +0.26% | +5.06% | +5.33% | +17.84% | -29.92% | +44.86% | +4.59% | +9.33% | -1.16% | +20.79% | -11.07% | -15.36% | -10.75% | -4.27% | +10.88% | +16.76% | -17.70% | -13.20% | +15.65% | +51.81% | -73.44% | +63.97% | -39.18% | +47.82% | +79.34% | -48.86% | +45.27% | n/a |
| Research and Development Revenue | 5.11M | 4.84M | 15.63M | 5.13M | 3.77M | 1.79M | 72.19K | 1.31M | 1.9M | 798.25K | 2.11M | 2.43M | 1.5M | 2.11M | 1.97M | 2.92M | 2.58M | 3.14M | 2.17M | 1.53M | 1.66M | 1.74M | 1.52M | 1.7M | 1.36M | 1.17M | 1.39M | 1.83M | 1.14M | 1.76M | 1.18M | 1.01M | 1.51M | 1.94M | 1.44M | 2.35M | 492.92K | 692.71K | 1.12M | 1.55M |
| Research and Development Revenue Growth | +5.59% | -69.04% | +204.90% | +35.87% | +110.61% | +2381.12% | -94.49% | -31.25% | +138.52% | -62.15% | -13.07% | +61.20% | -28.54% | +6.74% | -32.34% | +12.94% | -17.72% | +44.41% | +41.66% | -7.48% | -4.88% | +14.82% | -10.71% | +24.54% | +16.67% | -15.89% | -23.82% | +59.89% | -35.08% | +49.07% | +17.06% | -33.38% | -22.09% | +34.40% | -38.59% | +377.32% | -28.84% | -37.92% | -28.09% | n/a |